Synthetic pig cutaneous development substance (rrhEGF) is receiving increased recognition as a promising approach in the domain of wound medicine. This bioactive molecule, created through recombinant technology, offers https://recombinant-porcine-egf169732.jiliblog.com/99379074/engineered-pig-cutaneous-growth-factor-a-effective-tool-for-tissue-repair